The study, published in Cancers clinical journal, showed that VivoSight’s powerful Dynamic OCT (D-OCT) capability for detecting and imaging blood vessels in skin has the potential to help dermatologists non-invasively distinguish melanomas from suspicious nevi in unclear cases. According to the paper authors, adding D-OCT imaging to clinic-dermoscopic examination may: In the study, D-OCT images ...